Document Detail


Haemostasis and pregnancy.
MedLine Citation:
PMID:  16525566     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Normal pregnancy is associated with profound alterations in the coagulation and fibrinolytic systems. While these physiological procoagulant changes are aimed to minimise intrapartum blood loss, they do increase the risk of thromboembolism during pregnancy and the post-partum period. In contrast and more rarely, haemorrhage due to an underlying inherited or acquired bleeding disorder may occur and complicate a pregnancy. Based on an analysis of the literature data, this review presents an overview of the main thrombotic and haemorrhagic disorders complicating pregnancy.
Authors:
Massimo Franchini
Related Documents :
19716166 - Heparin and maternal fetal interface: why should it work to prevent pregnancy complicat...
9620096 - Controversies in antithrombotic therapy for patients with mechanical heart valves.
16154846 - The association between hereditary thrombophilias and pregnancy loss.
22551726 - Comparative safety of antiepileptic drugs during pregnancy.
7877236 - Arterial dissections associated with pregnancy.
16303866 - Adolescent smoking in pregnancy and birth outcomes.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  95     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-09     Completed Date:  2006-04-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  401-13     Citation Subset:  IM    
Affiliation:
Servizio di Immunoematologia e Trasfusione, Ospedale Policlinico, Piazzale L. Scuro, 10, 37134 Verona, Italy. mfranchini@univr.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Antiphospholipid Syndrome / blood,  complications,  drug therapy
Blood Coagulation / drug effects
Female
HELLP Syndrome / blood,  drug therapy
Hemophilia A / blood,  drug therapy
Hemostasis / drug effects*
Humans
Postpartum Hemorrhage / etiology*,  prevention & control
Pregnancy
Pregnancy Complications, Cardiovascular / etiology*,  prevention & control
Pregnancy Complications, Hematologic / blood,  drug therapy*
Purpura, Thrombotic Thrombocytopenic / blood,  drug therapy
Randomized Controlled Trials as Topic
Risk Factors
Thrombosis / etiology*,  prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants
Comments/Corrections
Comment In:
Thromb Haemost. 2007 Feb;97(2):322   [PMID:  17264966 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aggregation modes in sheets formed by protected beta-amino acids and beta-peptides.
Next Document:  Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in ...